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F i r s t s u c c e s s f u l attempts t o mimick immunogenic s i t e s of v i r a l s u r f a c e s by s y n t h e t i c r e p t i d e s d a t e back t o 1963 when Anderer was a b l e t o demonstrate t h a t a n t i b o d i e s t o s h o r t fragments of t h e tobacco mosaic v i r a l p r o t e i n i n t e r a c t with t h e i n t a c t v i r i o n ( r e f . 1). F u r t h e r s t u d i e s led t o t h e concept of s y n t h e t i c vaccines and r e s u l t e d i n a number of a c t i v e p e p t i d e preparat i o n s r e l a t e d t o such major i n f e c t i o n s a s i n f l u e n z a ( r e f s . 2 , 3 ) , h e p a t i t i s B ( r e f s . 4-6), p o l i o m y e l i t i s ( r e f . 7 ) .

According t o modern views an e f f i c i e n t peptide vaccine must c o n t a i n segments r e s p o n s i b l e f o r i n t e r a c t i o n with major subpopulations of imunocompetent c e l l s : B-epitopes f o r B-lymphocytes,
T-epitopes f o r T-helpers and s o c a l l e d agretopes recognized by t h e I a a n t i g e n a t t h e s u r f a c e of a n t i g e n p r e s e n t i n g c e l l s ( Fig. 1) (Note a ) .
c o n s t r u c t ion of t h e a n t it i d e v a c c i n e . 
T-cell
Peptide vaccine
I n t h e mid-80ies we began our s t u d i e s of s y n t h e t i c vaccines. Foot and mouth d i s e a s e (FMD) was chosen a s t h e f i r s t o b j e c t , t h e choice being influenced by t h e r e c e n t progress i n two groups ( r e f s . 8 , 9 ) . We synthesized two l a r g e s e r i e s of peptides from t h e main immunogenic 130-160 sequence of t h e VP1 p r o t e i n of 0 1 K and 822 v i r a l s t r a i n s and found among them p e p t i d e s c h i c h i n t h e f r e e s t a t e ( i . e . without high molecular c a r r i e r ) were a b l e t o p r o t e c t v a r i o u s animal s p e c i e s from t h e i n f e c t i o n . The b e s t p r o t e c t i v e p e p t i d e s a r e shown by t h i c k l i n e s i n F i g . 2.
Moreover, we were a b l e t o l o c a t e by immunochemical means approximate B-and T-epitopes i n these p e p t i d e s , t h e r e s u l t s being complementary t o d a t a of o t h e r i n v e s t i g a t o r s ( r e f s . 10,ll). R e s u l t s of t h e s e s t u d i e s a r e summarized i n t h e reviews ( r e f s . 12,13). It i s of importance t h a t some of t h e p e p t i d e s obtained were a c t i v e n o t only i n small l a b o r a t o r y animals b u t a l s o i n a g r i c u l t u r a l ones (Table 1) .
I n summary, t h e p r i n c i p a l f e a s i b i l i t y of e f f i c i e n t anti-FMD p e p t i d e vaccine i s now beyond doubt, i t s c o m e r i a l value being dependent upon such parameters a s d u r a t i o n of p r o t e c t i o n , c o s t , s t a b i l i t y on s t o r a g e , e t c . S t i l l , t h e r e i s a long way t o go b e f o r e t h e optimal synthet i c c o n s t r u c t i o n with r e s p e c t t o a l l t h e s e p r o p e r t i e s i s reached.
On t h e o t h e r hand considerable advances achieved i n t h e induction of p r o t e c t i o n a g a i n s t FMD by s y n t h e t i c p e p t i d e s a r e a t l e a s t p a r t i a l l y explained by t h e unique s t r u c t u r e of t h e FMD v ir u s . I t i s t h e only member of t h e family of picorna-viruses which has a s e q u e n t i a l immunodominant region exposed on t h e s u r f a c e of t h e v i r i o n ( r e f .
5 ) . Furthermore, a c h a r a c t e r i s t i c f e a t u r e of t h e v i r u s i s t h a t t h e main immunogenic region c o n t a i n s a s i t e f o r t h e binding of v i r u s t o t h e h o s t c e l l ( t h e 145-148 sequence of p r o t e i n VP1, r e f , 6 ) , s o t h a t t h e high a n t iv i r a l a c t i v i t y of t h e a n t i b o d i e s induced by t h e s y n t h e t i c p e p t i d e s might be due t o blocking of t h e sequence involved i n binding t h e v i r u s t o t h e c e l l r e c e p t o r .
Vote a: Since agretopes and T-epitopes a r e u s u a l l y l o c a t e d a t t h e same r e g i o n of t h e p r o t e i n molecule t h e term 'IT-epitope" o f f e n r e f e r s t o both s i t e s 18 for a review), the selected peptides synthesized and studied for biological activity in the free state (antigenicity) and as conjugates with protein carriers: bovine serum albumin, keyhole limpet haemocyanin (KLH) or gelatine (imunogenicity).
As seen from Table 2 sera taken from the human recovered after HAV infection and containing high titers of antiviral antibodies recognizes none of the peptides tested. Moreover, none of the antipeptide sera binds to the intact virus or neutralizes the viral infectivity in the cell culture. It is also known (ref. 20 ) that antibodies to denatured proteins VP1, VP2 and VP3 do not bind the virus and do not inhibit its growth i n vitro. In all probability the sites of viral recognition and neutralizatj.on with antibodies in case of HAT?, contrary to FMD belong to the class of conformational B-epitopes, i.e. they are made up of a number of peptide segments separated along the amino acid sequence or even belonging to different proteins of the viral particle.
Modeling such sites presents a considerable challange to a synthetic chemist. A hypothetic approach to the problem which is currently under study in our laboratory is depicted in Fig. 3 . Relatively short peptide segments representing the putative parts of conformational B-epitopes are anchored in the lipid bilayer with the help of long hydrophobic radicals. Due to mobility of the lipid phase they can freely assemble forming structures resembling the . This allowed us to synthesize a set of peptides from the established sequence and to study biological properties of these peptides and of respective KLH-conjugates ( Table 3 ) .
Free peptides except for 35-51 were not antigenic, i.e. they did not bind antibodies to protein E. They were also nonimmunogenic (did not induce antibodies), they did not inhibit the viral growth in v i t r o and had no protective activity in V i m . As expected, the KLH-conjugates were better immunogens and, moreover, two of them induced virus neutralizing antibodies. Further studies revealed a surprisingly broad spectrum of biological activities for the 98-113 peptide. This peptide inhibits viral entry to the macrophages, stimulates the phagocytic activities of macrophages and strongly inhibits the immune reaction (8-10 fold suppression of antibody forming spleen cells to sheep erythrocytes) at intrabrain application. We believe that these data are indicative of an important role of the 98-113 segment in the virus-host interactions Apparently, studies of synthetic peptide vaccines besides serving the main purpose might provide valuable information on the molecular mechanisms of viral pathogenicity, suggesting new ways for treating viral discases. 
